The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Mosaic Company shares plummeted to their lowest level in over five years after reporting adjusted earnings of $0.05 per share, missing the consensus estimate of $0.24 by a wide margin. According to reports, the company withdrew its 2026 phosphate production guidance and specifically lowered its capital expenditure budget to $1.25 billion from the previously planned $1.5 billion. These developments prompted CIBC to slash its price target for MOS stock from $27.00 to $25.00.
This sharp contraction highlights a significant performance gap relative to industry peers, as market data shows companies like Nutrien and CF Industries maintaining more resilient valuations despite sector-wide margin pressure. Mosaic's profitability was uniquely crippled by surging sulfuric acid costs, which fueled the nearly 90% earnings plunge and triggered aggressive downward revisions compared to global fertilizer rivals per market data.
Sign in to access this content
Sign InTraders are closely watching MOS shares as they hover near the $25.00 level (close May 12, 2026), testing historical support following the multi-year low. Looking ahead, the market focus shifts to the U.S. Producer Price Index (PPI) release on May 14, 2026, which will provide critical data on industrial input inflation and the potential for margin stabilization in the coming quarters.
Update: Additional reports indicate that the ongoing Iran war has played a pivotal role in exacerbating the company's financial struggles by disrupting global supply chains. These geopolitical tensions have driven an unexpected surge in raw material costs, contributing directly to the net loss reported by Mosaic for the first quarter.
Update: In an effort to streamline operations, Mosaic is idling specific assets to curb costs amid geopolitical disruptions impacting global supply chains. Conversely, the company is pivoting toward its Biosciences platform, where it projects revenue to double this year driven by new product launches, potentially offering a strategic hedge against the headwinds in its core fertilizer business.
Update: Despite the earnings miss, Mosaic reported revenue of $3.00 billion, beating analyst estimates by 9%, though UBS subsequently lowered its price target to $23.00. The company highlighted that geopolitical conflicts in the Persian Gulf and Ukraine continue to disrupt the flow of essential raw materials.